Zimmer Biomet in the news

Zimmer Biomet plans to cut 580 jobs in its Winterthur, Switzerland plant as part of a manufacturing network optimization strategy.

Zimmer Biomet has restructured its Americas leadership team, promoting three executives and seeing one depart, to streamline operations and accelerate commercial transformation.

A Zimmer Biomet executive sold 3,000 shares of company stock for about $295,000.

Zimmer Biomet is restructuring its leadership team, resulting in the departure of Kevin Thornal and several key promotions, ahead of a new robot launch and impacting stock performance.

An insider at Zimmer Biomet sold 3,000 shares of the company's stock for over $295,000, while the company reported strong earnings and announced a dividend.

An insider at Zimmer Biomet Holdings sold shares worth $295,050, and the document also outlines various investment rating methodologies.

Zimmer Biomet's Group President, Kevin Thornal, will depart in 2026 due to a restructuring that eliminated his role, and he will receive severance.

Zimmer Biomet Holdings Inc. stock underperformed competitors and the broader market, falling 3.93% on Tuesday for its third consecutive day of losses.

Kevin Thornal, Group President at Zimmer Biomet, will leave the company on September 30, 2026, with severance, as his position has been restructured.

Zimmer Biomet promoted three executives to key leadership roles to enhance agility and accelerate market growth in its Americas and Global Business Group, while also confirming its 2026 financial outlook.

Zimmer Biomet announced several key executive promotions and one departure as part of a restructuring effective October 1, 2026.

Zimmer Biomet announced three key leadership promotions within its Americas and Global Business Group, effective October 1, 2026, to streamline operations, accelerate commercial transformation, and enhance strategic focus.

Zimmer Biomet Holdings (ZBH) stock dropped by 4.6% today, attributed to a wider medtech market decline rather than specific company announcements, amidst mixed insider and institutional trading activities.

HSBC Holdings PLC increased its stake in Zimmer Biomet, a global medical technology leader, which also reported strong Q2 earnings and declared a dividend.

Nykredit A S initiated a $3.42 million position in Zimmer Biomet Holdings, Inc. during the second quarter, while the company reported strong earnings and announced a quarterly dividend.

Munich Reinsurance Co Stock Corp initiated a $3.75 million position in Zimmer Biomet Holdings, Inc., a medical equipment provider.

Zimmer Biomet officer Chad F. Phipps plans to sell 3,000 common shares worth over $295,000 in September 2026.

Zimmer Biomet is moving its headquarters, donating its current building to Grace College, and consolidating manufacturing and distribution operations in Warsaw and Indianapolis.

Zimmer Biomet donated its global headquarters to Grace College and will move its headquarters to its largest manufacturing facility in Warsaw.

Zimmer Biomet reported better-than-expected Q2 2026 earnings and revenues, with strong growth in its Technology & Data, Bone Cement and Surgical segment.